Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing

NCT02350010 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2015-01-29

No results posted yet for this study

Summary

There were lack of data and analysis about medical management, etiology, and long-term outcome of Intracerebral Hemorrhage (ICH) in Beijing. In this study the investigators do acute CT angiography, a non-invasive imaging method to explore etiology and prognostic risk factors of ICH. Further the investigators will aim to develop and validate a risk score for predicting 1-year functional outcome after ICH.

Conditions

  • Intracerebral Hemorrhage

Interventions

DEVICE

CT Angiography

CTA Scan with the specified sequences below: 120 kVp, 360 mAs, 0.5 second/rotation, 0.75 mm thick with a pitch of 0.65. Coronal and sagittal multiplanar reconstructed images with 10.0-mm-thick images spaced by 3 mm. Axial reformed images were 4 mm thick with 2-mm spacing. 90 mL of nonionic iodinated contrast (OPTIRAY 350) at 5 mL/s.

Sponsors & Collaborators

  • Peking University Third Hospital

    collaborator OTHER
  • Beijing Tiantan Hospital

    collaborator OTHER
  • Beijing Shijitan Hospital, Capital Medical University

    collaborator OTHER
  • KaiLuan General Hospital

    collaborator OTHER
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER
  • People's Hospital of Beijing Daxing District

    collaborator OTHER
  • Beijing Aerospace General Hospital

    collaborator OTHER
  • Beijing Haidian Hospital

    collaborator OTHER
  • Beijing Fangshan District Liangxiang Hospital

    collaborator OTHER
  • The 263 Hospital of PLA

    collaborator UNKNOWN
  • General Hospital of Beijing PLA Military Region

    collaborator OTHER
  • Peking University Aerospace Center Hospital

    collaborator OTHER
  • Beijing Renhe Hospital

    collaborator UNKNOWN
  • Beijing Pinggu District Hospital

    collaborator OTHER
  • Beijing Shuyi Hospital

    collaborator OTHER
  • Beijing Huairou Hospital

    collaborator OTHER
  • Beijing Luhe Hospital

    collaborator OTHER
  • Fu Xing Hospital, Capital Medical University

    collaborator OTHER
  • Beijing Neurosurgical Institute

    lead OTHER

Principal Investigators

  • Wen-Zhi Wang, professor · Beijing Neurosurgical Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-03-31
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02350010 on ClinicalTrials.gov